EMST 150 Training in Mild-Moderate OSA
Evaluating the Efficacy and Feasibility of Combined Expiratory Muscle Strength Training (EMST 150) and Oropharyngeal Myofunctional Therapy in Patients With Mild-to-Moderate Obstructive Sleep Apnea.
Obstructive Sleep Apnea is a condition in which the upper airway repeatedly becomes blocked during sleep, often due to weakness or collapse of the upper airway throat muscles. The purpose of this study is to evaluate whether combining a handheld breathing device (Expiratory Muscle Strength Training (EMST 150)) with structured, speech-language pathology-Guided mouth and throat exercises can help strengthen the muscles that keep the airway open, reduce snoring, and reduce sleep apnea severity while improving overall sleep quality. Participation in this study will last about 3 months. This includes a 5-week home breathing exercise program, two in-person clinic visits (at the beginning of the study and at Month 3), and two short phone check-ins.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Thomaz Fleury Curado, MD
- Numero di telefono: 216-844-1716
- Email: thomaz.fleurycurado@uhhospitals.org
Luoghi di studio
-
-
Ohio
-
Cleveland, Ohio, Stati Uniti, 44106
- University Hospitals Cleveland Medical Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Clinical diagnosis of Mild-to-Moderate OSA (5<AHI<30 events/hour)
- Patient willingness and physical capability to perform threshold-based respiratory exercises and daily oral myofunctional exercises.
- Documented failure, intolerance (defined as regular use < 4 hours/night), or patient refusal of standard therapies, including Continuous Positive Airway Pressure (CPAP) and surgical interventions.
Exclusion Criteria:
- Severe OSA (AHI>30 events/hour)
- Active asthma, severe or poorly controlled asthma with low symptom perception, or severe chronic obstructive pulmonary disease (COPD)
- Uncontrolled hypertension, defined as resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg at screening, or any change in antihypertensive medication within the past 30 days, or significant cardiovascular disease.
- Recent esophageal surgery, recent abdominal surgery, or presence of an abdominal hernia.
- History of spontaneous pneumothorax, or incomplete recovery/healing following traumatic pneumothorax or rib fracture.
- History of lung transplantation or lung resection.
- Current tracheostomy or unhealed tracheostomy stoma.
- Presence of a cerebrospinal fluid (CSF) drain or active intracranial pressure monitoring.
- Active epistaxis (frequent/severe nosebleeds) or active hemoptysis within the past 30 days.
- Tympanic membrane perforation (ruptured eardrum) or active inner/middle ear pathology.
- Unrelated or uncontrolled gastroesophageal reflux disease (GERD).
- Known or suspected pregnancy.
- Active use of CPAP, mandibular advancement device (MAD), or hypoglossal nerve stimulation (HGNS) during the study period.
- Any acute medical condition or clinical situation where generating intrathoracic, intro-abdominal, or intracranial pressure (similar to Valsalva maneuver) is clinically contraindicated.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Participants with Obstructive Sleep Apnea (OSA)
Adult participants diagnosed with mild-to-moderate obstructive OSA. |
Participants utilize the EMST 150 device to strengthen expiratory and upper airway musculature. During training, participants inhale deeply and exhale forcefully through the mouthpiece again calibrated resistance while maintaining an airtight lip seal to overcome the target threshold pressure. Participants perform structured oral motor exercises :
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI)
Lasso di tempo: Baseline, 3 months
|
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire that evaluates overall sleep quality and disturbances over a one-month time interval. With higher scores indicating poor sleep quality. |
Baseline, 3 months
|
|
Change in Daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS)
Lasso di tempo: Baseline, 3 months
|
The Epworth Sleepiness Scale (ESS) is a short, self-administered questionnaire used to measure a person's general level of daytime sleepiness and likelihood of dozing off in everyday situations. Scored on a scale from 0 would never doze, to 3 high chance of dozing. |
Baseline, 3 months
|
|
Snore score as measured by smartphone application monitoring.
Lasso di tempo: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Percentage of snoring sleep time as measured by smartphone application monitoring.
Lasso di tempo: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Noise intensity in decibels as measured by smartphone application monitoring.
Lasso di tempo: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Change in Isometric maximal tongue pressure (kPa) as measured by the Iowa Oral Performance Instrument (IOPI)
Lasso di tempo: Baseline, 3 months
|
The Iowa Oral Performance Instrument (IOPI) is a portable, evidence-based medical device used to objectively measure, document, and train lip and tongue strength and endurance. The device digitally records maximum isometric pressure in kilopascals |
Baseline, 3 months
|
|
Change in tongue muscle endurance as measured by time in seconds sustained at 50% maximal pressure.
Lasso di tempo: Baseline, 3 months
|
Time in seconds sustained at 50% maximal pressure. |
Baseline, 3 months
|
|
Change in Apnea-Hypopnea Index (AHI)
Lasso di tempo: Baseline, 3 months
|
The apnea-hypopnea index (AHI) is the average number of breathing pauses (apneas) and shallow breathing events (hypopneas) that occur per hour of sleep, with higher scores indicating greater sleep apnea severity. |
Baseline, 3 months
|
|
Change in Maximum Expiratory Pressure (MEP)
Lasso di tempo: Baseline, 3 months
|
MEP is the highest positive pressure generated by a person during a forced exhalation against a blocked airway. It measures the strength of the expiratory muscles, including the abdominal and internal intercostal muscles, and helps evaluate cough efficiency and neuromuscular function. Lower scores indicate generalized respiratory muscle weakness, chronic obstructive pulmonary disease (COPD), or neuromuscular conditions like myasthenia gravis or Guillain-Barré syndrome. |
Baseline, 3 months
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Investigatore principale: Thomaz Fleury Curado, MD, University Hospitals Cleveland Medical Center
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- STUDY20261102
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .